TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+5.11%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$64M
(+2.5%)
Cap. Flow
-$37M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
198
New
11
Increased
45
Reduced
37
Closed
18
Top Buys
| 1 |
UnitedHealth
UNH
|
$17.9M |
| 2 |
Stryker
SYK
|
$12.2M |
| 3 |
AstraZeneca
AZN
|
$11.8M |
| 4 |
Danaher
DHR
|
$11.6M |
| 5 |
Pfizer
PFE
|
$11.2M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$19M |
| 2 |
SHPG
Shire pic
SHPG
|
$13.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.2M |
| 4 |
Abbott
ABT
|
$10.5M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$8.69M |
Sector Composition
| 1 | Healthcare | 92.61% |
| 2 | Real Estate | 3% |
| 3 | Financials | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
51
Diversified Healthcare Trust
DHC
$995M
| $11.7M | 0.44% |
646,554
| – | – |
|
|
BLUE
52
DELISTED
bluebird bio
BLUE
| $11.3M | 0.43% |
5,574
+455
| +9% | +$925K |
|
53
Intuitive Surgical
ISRG
$167B
| $11.2M | 0.43% |
70,437
+27,783
| +65% | +$4.43M |
|
|
DPLO
54
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $11.2M | 0.43% |
439,001
| – | – |
|
55
FibroGen
FGEN
$48.9M
| $11.2M | 0.42% |
7,128
+2,956
| +71% | +$4.63M |
|
56
Acadia Healthcare
ACHC
$2.19B
| $11.1M | 0.42% |
272,400
| – | – |
|
|
PVLA
57
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $10.6M | 0.4% |
26,092
| – | – |
|
58
CRISPR Therapeutics
CRSP
$4.99B
| $10.5M | 0.4% |
178,348
+37,157
| +26% | +$2.18M |
|
|
ENDP
59
DELISTED
Endo International plc
ENDP
| $10.2M | 0.39% |
1,078,414
+163,866
| +18% | +$1.55M |
|
|
ADAP
60
Adaptimmune Therapeutics
ADAP
$10.9M
| $10.2M | 0.39% |
855,468
| – | – |
|
|
GWPH
61
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.98M | 0.38% |
71,497
-39,287
| -35% | -$5.48M |
|
62
Baxter International
BAX
$12.5B
| $9.9M | 0.38% |
134,124
+94,159
| +236% | +$6.95M |
|
63
Edwards Lifesciences
EW
$47.5B
| $9.65M | 0.37% |
198,825
| – | – |
|
64
Merus
MRUS
$5.1B
| $9.43M | 0.36% |
414,115
-65,035
| -14% | -$1.48M |
|
|
BPMC
65
DELISTED
Blueprint Medicines
BPMC
| $9.27M | 0.35% |
146,001
+71,780
| +97% | +$4.56M |
|
66
Nektar Therapeutics
NKTR
$764M
| $9.22M | 0.35% |
12,585
+4,284
| +52% | +$3.14M |
|
67
Exelixis
EXEL
$10.2B
| $9.21M | 0.35% |
428,022
+39,200
| +10% | +$844K |
|
|
CLLS
68
Cellectis
CLLS
$269M
| $9M | 0.34% |
317,950
+34,700
| +12% | +$982K |
|
|
LTC
69
LTC Properties
LTC
$1.69B
| $8.96M | 0.34% |
209,673
| – | – |
|
|
MDCO
70
DELISTED
Medicines Co
MDCO
| $8.76M | 0.33% |
238,741
-39,650
| -14% | -$1.46M |
|
|
ONC
71
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $8.42M | 0.32% |
54,785
+5,289
| +11% | +$813K |
|
|
XLRN
72
DELISTED
Acceleron Pharma Inc.
XLRN
| $8.29M | 0.31% |
170,766
-102,332
| -37% | -$4.97M |
|
|
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
| $8.22M | 0.31% |
106,500
| – | – |
|
74
Galapagos
GLPG
$2.2B
| $8M | 0.3% |
86,815
-8,820
| -9% | -$813K |
|
75
Cencora
COR
$56.7B
| $7.91M | 0.3% |
92,707
| – | – |
|